CME/CE
Your professional development is critical to the care of your patients. Stay on top of the latest treatments and information with ReachMD's CME activities. Our topics span cardiology, diabetes, oncology, women's health and more. And our CME library is continuously growing, every quarter.
346-360 of 1027
The Critical Interplay: CKD, HF, and HyperkaleAmia
MinuteCE®The Critical Interplay: CKD, HF, and HyperkaleAmia
James Burton, DM, FRCP
Javed Butler, MD
Ellie Kelepouris, MD, FACP, FAHA
Patrick Rossignol, MD, PhD
Meghan Sise, MD
Emerging Therapies in Managing Adult and Pediatric Patients With FSGS: Latest Data
MinuteCE®Emerging Therapies in Managing Adult and Pediatric Patients With FSGS: Latest Data
Vladimir Tesar
Meghan Sise, MD
Kenneth Lieberman, MD
Meghan Sise, MD
Vladimir Tesar
Monitoring FSGS: Traditional and Novel Biomarkers
MinuteCE®Monitoring FSGS: Traditional and Novel Biomarkers
Meghan Sise, MD
Vladimir Tesar
Integrating the Patient Voice in FSGS Management
MinuteCE®Integrating the Patient Voice in FSGS Management
Meghan Sise, MD
- advertisement
Current FSGS Treatment Landscape: More Questions Than Answers
MinuteCE®Current FSGS Treatment Landscape: More Questions Than Answers
Vladimir Tesar
Meghan Sise, MD
Treatment Considerations for Pediatric Patients With FSGS
MinuteCE®Treatment Considerations for Pediatric Patients With FSGS
Kenneth Lieberman, MD
Bronchiectasis Update: Diagnostic Innovations and Therapeutic Frontiers
CME/CEBronchiectasis Update: Diagnostic Innovations and Therapeutic Frontiers
Christopher J. Richards, MD
Ashley Losier, MD
FSGS: Interpretation of Proteinuria Reduction Thresholds
MinuteCE®FSGS: Interpretation of Proteinuria Reduction Thresholds
Vladimir Tesar
Meghan Sise, MD
DEARA Versus SOC in FSGS Management: Clinical Trial Insights
MinuteCE®DEARA Versus SOC in FSGS Management: Clinical Trial Insights
Vladimir Tesar
Meghan Sise, MD
Kenneth Lieberman, MD
Vladimir Tesar
- advertisement
Photobiomodulation: A Non-Invasive Treatment for Ocular Disease and Trauma
MinuteCE®Photobiomodulation: A Non-Invasive Treatment for Ocular Disease and Trauma
Janis T. Eells, Ph.D.
Janis T. Eells, Ph.D.
David Boyer, MD
Diana V. Do, MD
Marion Munk, MD, Ph.D
Anatomical Outcomes from the LIGHTSITE III Trial
MinuteCE®Anatomical Outcomes from the LIGHTSITE III Trial
Diana V. Do, MD
David Boyer, MD
